POTASSIUM PHOSPHATE, MONOBASIC

POTASSIUM PHOSPHATE, MONOBASIC was reported 471 times

POTASSIUM PHOSPHATE, MONOBASIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA STAGE IV 2 0.0488
1 VAGINAL FLATULENCE 8 0.0264
2 AUDITORY NERVE DISORDER 1 0.0227
3 LEPTOTRICHIA INFECTION 1 0.0222
4 BILIRUBIN CONJUGATED ABNORMAL 2 0.0180
5 COVID-19 TREATMENT 1 0.0147
6 PREMATURE BABY DEATH 1 0.0122
7 BACILLUS INFECTION 7 0.0111
8 SERRATIA TEST POSITIVE 1 0.0103
9 HYDROPNEUMOTHORAX 1 0.0097
10 POST-DEPLETION B-CELL RECOVERY 1 0.0088
11 POLYOMAVIRUS TEST POSITIVE 1 0.0085
12 NEONATAL HYPONATRAEMIA 1 0.0082
13 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
14 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
15 NECROTISING ENTEROCOLITIS NEONATAL 3 0.0074
16 CARBOHYDRATE ANTIGEN 27.29 INCREASED 1 0.0067
17 ACUTE PHOSPHATE NEPHROPATHY 1 0.0064
18 METASTASES TO SPINAL CORD 1 0.0052
19 STENT MALFUNCTION 1 0.0051
20 ORAL BLOOD BLISTER 1 0.0050
21 SEPSIS NEONATAL 4 0.0049
22 FEMALE GENITAL TRACT FISTULA 8 0.0047
23 THROMBOSIS MESENTERIC VESSEL 1 0.0044
24 ANORECTAL INFECTION 1 0.0040
25 GRAFT THROMBOSIS 1 0.0038
26 GALLBLADDER OBSTRUCTION 1 0.0038
27 ENTEROCOCCAL SEPSIS 3 0.0037
28 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
29 AVULSION FRACTURE 1 0.0035
30 ASPERGILLOMA 1 0.0031
31 RADICULOPATHY 8 0.0030
32 ILEAL PERFORATION 2 0.0030
33 OCULAR MYASTHENIA 1 0.0029
34 METASTATIC GASTRIC CANCER 1 0.0029
35 URETERAL STENT INSERTION 1 0.0029
36 PROCTITIS 8 0.0029
37 PSEUDOMONAL SEPSIS 5 0.0029
38 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
39 MULTIPLE SYSTEM ATROPHY 1 0.0028
40 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
41 NEONATAL HYPOTENSION 1 0.0027
42 FLUID INTAKE REDUCED 13 0.0026
43 ASYMPTOMATIC COVID-19 1 0.0025
44 LUNG CYST 1 0.0025
45 VITAMIN K DEFICIENCY 1 0.0025
46 SPUTUM CULTURE POSITIVE 2 0.0025
47 SEIZURE CLUSTER 2 0.0024
48 HAEMOBILIA 1 0.0024
49 TOXIC EPIDERMAL NECROLYSIS 36 0.0024
50 HYPERFERRITINAEMIA 1 0.0023
51 HYPERTRANSAMINASAEMIA 16 0.0023
52 PSEUDOMONAS INFECTION 19 0.0022
53 CIRRHOSIS ALCOHOLIC 1 0.0022
54 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 1 0.0021
55 CULTURE URINE POSITIVE 3 0.0021
56 CHRONIC SINUSITIS 8 0.0021
57 BLAST CELLS PRESENT 1 0.0021
58 BLOOD URIC ACID DECREASED 1 0.0021
59 RIGHT ATRIAL DILATATION 1 0.0020
60 BLOOD PHOSPHORUS DECREASED 7 0.0019
61 DRUG LEVEL ABNORMAL 1 0.0019
62 HYPERTENSIVE URGENCY 1 0.0018
63 ESCHERICHIA TEST POSITIVE 2 0.0017
64 SACRAL PAIN 1 0.0016
65 BLOOD BILIRUBIN ABNORMAL 2 0.0016
66 ENTEROCOCCUS TEST POSITIVE 1 0.0015
67 LUNG TRANSPLANT REJECTION 1 0.0015
68 URETERIC OBSTRUCTION 2 0.0015
69 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
70 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
71 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
72 ANTIBODY TEST ABNORMAL 1 0.0014
73 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
74 HYPOPHOSPHATAEMIA 10 0.0014
75 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
76 SERRATIA INFECTION 1 0.0013
77 MACULAR DEGENERATION 16 0.0013
78 HEART SOUNDS ABNORMAL 1 0.0013
79 PULMONARY INFARCTION 3 0.0013
80 COLORECTAL CANCER METASTATIC 3 0.0013
81 RESPIRATORY ALKALOSIS 2 0.0012
82 INFANTILE APNOEA 1 0.0012
83 PSEUDOMONAS TEST POSITIVE 1 0.0012
84 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
85 NEONATAL HYPOXIA 1 0.0012
86 HEPATIC HAEMORRHAGE 1 0.0012
87 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
88 FANCONI SYNDROME ACQUIRED 2 0.0011
89 ABDOMINAL SEPSIS 1 0.0011
90 RENAL TUBULAR ATROPHY 1 0.0011
91 BLOOD ALBUMIN INCREASED 1 0.0011
92 BLOOD MAGNESIUM INCREASED 1 0.0011
93 CATHETER RELATED INFECTION 1 0.0010
94 NEUTROPENIC COLITIS 2 0.0010
95 BACTERIAL SEPSIS 3 0.0009
96 KLEBSIELLA SEPSIS 1 0.0009
97 CARBON DIOXIDE DECREASED 1 0.0009
98 EPIDIDYMITIS 1 0.0009
99 CYTOMEGALOVIRUS INFECTION 14 0.0008
100 CLOSTRIDIUM COLITIS 1 0.0008
101 RESPIRATORY FAILURE 60 0.0008
102 MONOCYTE COUNT DECREASED 1 0.0008
103 LARGE INTESTINE INFECTION 1 0.0008
104 BLOOD UREA DECREASED 1 0.0008
105 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
106 VAGINAL DISCHARGE 8 0.0008
107 LEFT ATRIAL DILATATION 1 0.0008
108 TONGUE DRY 1 0.0007
109 VIRAEMIA 1 0.0007
110 PERITONEAL HAEMORRHAGE 1 0.0007
111 HYPERTONIC BLADDER 2 0.0007
112 OSTEOMALACIA 1 0.0006
113 FUNGAEMIA 1 0.0006
114 NEONATAL DISORDER 1 0.0006
115 METABOLIC ALKALOSIS 1 0.0006
116 ORAL CANDIDIASIS 8 0.0006
117 ORGANISING PNEUMONIA 3 0.0006
118 BLOOD CALCIUM ABNORMAL 1 0.0006
119 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
120 SPLEEN DISORDER 1 0.0006
121 INJECTION SITE OEDEMA 1 0.0006
122 BLOOD CHLORIDE INCREASED 1 0.0006
123 KIDNEY FIBROSIS 1 0.0006
124 EXTREMITY NECROSIS 1 0.0006
125 PARAESTHESIA ORAL 8 0.0006
126 DEVICE ALARM ISSUE 1 0.0006
127 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
128 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
129 PNEUMONIA KLEBSIELLA 1 0.0005
130 OESOPHAGEAL SPASM 1 0.0005
131 FEBRILE NEUTROPENIA 36 0.0005
132 DISORGANISED SPEECH 1 0.0005
133 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
134 BLOOD BICARBONATE DECREASED 1 0.0005
135 HYPOPROTEINAEMIA 1 0.0005
136 OSTEOPOROTIC FRACTURE 1 0.0005
137 GINGIVAL RECESSION 1 0.0005
138 RENAL FAILURE CHRONIC 4 0.0005
139 METASTASES TO LUNG 6 0.0005
140 STAPHYLOCOCCAL INFECTION 17 0.0005
141 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
142 CYTOKINE RELEASE SYNDROME 10 0.0005
143 LIPIDS INCREASED 1 0.0005
144 CAPILLARY LEAK SYNDROME 1 0.0005
145 INSULIN RESISTANCE 1 0.0005
146 DILATATION VENTRICULAR 1 0.0005
147 FEBRILE BONE MARROW APLASIA 2 0.0005
148 SKIN ULCER 12 0.0005
149 CLOSTRIDIUM TEST POSITIVE 1 0.0005
150 BACTERIAL TEST POSITIVE 1 0.0004
151 BLOOD CALCIUM DECREASED 5 0.0004
152 ASCITES 13 0.0004
153 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
154 YELLOW SKIN 2 0.0004
155 URINARY TRACT OBSTRUCTION 1 0.0004
156 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
157 KIDNEY TRANSPLANT REJECTION 2 0.0004
158 TUMOUR MARKER INCREASED 2 0.0004
159 ENTEROCOCCAL INFECTION 2 0.0004
160 HAEMATOLOGICAL INFECTION 1 0.0004
161 SMALL INTESTINAL OBSTRUCTION 5 0.0004
162 CATHETER SITE HAEMORRHAGE 1 0.0004
163 HYPERPARATHYROIDISM SECONDARY 1 0.0004
164 SYSTEMIC CANDIDA 1 0.0004
165 URINARY TRACT INFECTION BACTERIAL 1 0.0004
166 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
167 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
168 LIPOMA 1 0.0004
169 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
170 COMPRESSION FRACTURE 2 0.0004
171 BLOOD SODIUM INCREASED 1 0.0004
172 BLOOD PHOSPHORUS INCREASED 1 0.0004
173 SUBDURAL HAEMORRHAGE 1 0.0004
174 HYPERKERATOSIS 2 0.0004
175 PLEURITIC PAIN 1 0.0004
176 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
177 SERUM SICKNESS 1 0.0004
178 MALNUTRITION 4 0.0004
179 TUMOUR HAEMORRHAGE 1 0.0004
180 BLOOD MAGNESIUM DECREASED 3 0.0003
181 ESCHERICHIA SEPSIS 1 0.0003
182 LUMBAR SPINAL STENOSIS 1 0.0003
183 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
184 PLATELET COUNT ABNORMAL 2 0.0003
185 CRANIOCEREBRAL INJURY 1 0.0003
186 PROCEDURAL PAIN 9 0.0003
187 DIASTOLIC DYSFUNCTION 1 0.0003
188 BLOOD CREATININE DECREASED 1 0.0003
189 BILE DUCT STONE 1 0.0003
190 ORTHOPNOEA 1 0.0003
191 PROCTALGIA 2 0.0003
192 ATELECTASIS 3 0.0003
193 HERPES SIMPLEX 2 0.0003
194 PRODUCT PREPARATION ISSUE 2 0.0003
195 SARS-COV-2 TEST POSITIVE 4 0.0003
196 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
197 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
198 PROSTATE CANCER METASTATIC 1 0.0003
199 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
200 METASTASES TO SPINE 1 0.0003
201 BK VIRUS INFECTION 1 0.0003
202 METASTASES TO LYMPH NODES 2 0.0003
203 FREQUENT BOWEL MOVEMENTS 8 0.0003
204 WOUND DEHISCENCE 1 0.0003
205 CLOSTRIDIAL INFECTION 1 0.0003
206 BONE MARROW FAILURE 6 0.0003
207 BLOOD CREATININE ABNORMAL 1 0.0003
208 RIGHT VENTRICULAR FAILURE 2 0.0003
209 BRONCHIOLITIS 1 0.0003
210 INCONTINENCE 3 0.0003
211 ASPIRATION 3 0.0003
212 AMYLASE INCREASED 1 0.0003
213 WOUND HAEMORRHAGE 1 0.0003
214 BONE DENSITY ABNORMAL 1 0.0003
215 HYPOCALCAEMIA 5 0.0003
216 HYPERTHERMIA 2 0.0003
217 ACIDOSIS 2 0.0003
218 ELECTROLYTE IMBALANCE 3 0.0003
219 OEDEMA 14 0.0003
220 LUNG INFECTION 4 0.0003
221 RHINOVIRUS INFECTION 1 0.0003
222 APNOEA 2 0.0003
223 ORAL INFECTION 1 0.0003
224 PNEUMONIA FUNGAL 1 0.0003
225 BLOOD ALBUMIN DECREASED 2 0.0003
226 ABSCESS 4 0.0003
227 VITAMIN B12 DEFICIENCY 1 0.0002
228 DECUBITUS ULCER 2 0.0002
229 PERIPHERAL ISCHAEMIA 1 0.0002
230 METASTASES TO BONE 4 0.0002
231 SELF-MEDICATION 1 0.0002
232 ILEUS 3 0.0002
233 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
234 HYPOKALAEMIA 11 0.0002
235 HALLUCINATIONS, MIXED 1 0.0002
236 COLITIS 9 0.0002
237 HYPERPYREXIA 1 0.0002
238 LIP OEDEMA 1 0.0002
239 SHOULDER OPERATION 1 0.0002
240 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
241 RECTAL HAEMORRHAGE 10 0.0002
242 MULTI-ORGAN FAILURE 4 0.0002
243 TONGUE DISCOLOURATION 1 0.0002
244 TACHYPNOEA 3 0.0002
245 NEPHROGENIC ANAEMIA 1 0.0002
246 LEUKAEMIA 2 0.0002
247 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
248 HYPOVOLAEMIC SHOCK 1 0.0002
249 HUMERUS FRACTURE 1 0.0002
250 FLUID OVERLOAD 3 0.0002
251 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
252 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
253 BREATH SOUNDS ABNORMAL 1 0.0002
254 ABDOMINAL TENDERNESS 1 0.0002
255 ECONOMIC PROBLEM 3 0.0002
256 PRODUCT ADMINISTRATION ERROR 4 0.0002
257 DYSPHORIA 1 0.0002
258 AMMONIA INCREASED 1 0.0002
259 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
260 PERIORBITAL OEDEMA 1 0.0002
261 ANAL ABSCESS 1 0.0002
262 GINGIVITIS 1 0.0002
263 BLOOD BILIRUBIN INCREASED 5 0.0002
264 PALLOR 5 0.0002
265 NONSPECIFIC REACTION 1 0.0002
266 ASTHENOPIA 1 0.0002
267 INTESTINAL ISCHAEMIA 1 0.0002
268 COLITIS ULCERATIVE 8 0.0002
269 CONDITION AGGRAVATED 53 0.0002
270 SKIN ATROPHY 1 0.0002
271 BLOOD URIC ACID INCREASED 1 0.0002
272 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
273 RALES 1 0.0002
274 HYPOVOLAEMIA 1 0.0002
275 ENERGY INCREASED 1 0.0002
276 COVID-19 PNEUMONIA 2 0.0002
277 BACTERAEMIA 2 0.0002
278 CARDIAC PACEMAKER INSERTION 1 0.0002
279 HAEMATOCHEZIA 9 0.0002
280 SEPTIC SHOCK 7 0.0002
281 INFUSION SITE EXTRAVASATION 1 0.0002
282 NASAL DRYNESS 1 0.0002
283 METABOLIC ACIDOSIS 5 0.0002
284 ACUTE RESPIRATORY FAILURE 3 0.0002
285 KIDNEY INFECTION 3 0.0002
286 HYPOGAMMAGLOBULINAEMIA 1 0.0002
287 ANHEDONIA 4 0.0002
288 BEDRIDDEN 2 0.0002
289 INFUSION RELATED REACTION 10 0.0002
290 CARDIAC FAILURE ACUTE 1 0.0001
291 MENINGITIS 1 0.0001
292 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
293 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
294 BREAST MASS 1 0.0001
295 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
296 NEPHROTIC SYNDROME 1 0.0001
297 ECCHYMOSIS 1 0.0001
298 RESPIRATION ABNORMAL 1 0.0001
299 HAIR GROWTH ABNORMAL 1 0.0001
300 LARGE INTESTINE PERFORATION 1 0.0001
301 HYPOMAGNESAEMIA 2 0.0001
302 RENAL FAILURE 19 0.0001
303 HYPONATRAEMIA 8 0.0001
304 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
305 HAND FRACTURE 1 0.0001
306 PRODUCT SUPPLY ISSUE 1 0.0001
307 NEUTROPENIC SEPSIS 1 0.0001
308 SUBDURAL HAEMATOMA 2 0.0001
309 HYPOTENSION 28 0.0001
310 COVID-19 24 0.0001
311 CARDIOMYOPATHY 2 0.0001
312 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
313 DISEASE PROGRESSION 16 0.0001
314 CEREBRAL DISORDER 1 0.0001
315 PULMONARY MASS 2 0.0001
316 HYDRONEPHROSIS 1 0.0001
317 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
318 OSTEOPENIA 2 0.0001
319 HAEMODYNAMIC INSTABILITY 1 0.0001
320 LIPASE INCREASED 1 0.0001
321 DEVICE RELATED INFECTION 2 0.0001
322 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
323 HYPOALBUMINAEMIA 1 0.0001
324 ACUTE MYELOID LEUKAEMIA 2 0.0001
325 TORSADE DE POINTES 1 0.0001
326 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
327 RENAL CYST 1 0.0001
328 ANAEMIA 24 0.0001
329 GINGIVAL PAIN 1 0.0001
330 OBESITY 2 0.0001
331 SEPSIS 14 0.0001
332 MYASTHENIA GRAVIS 1 0.0001
333 MENTAL IMPAIRMENT 3 0.0001
334 POLYURIA 1 0.0001
335 ABNORMAL FAECES 1 0.0001
336 MULTIPLE FRACTURES 2 0.0001
337 ESCHERICHIA INFECTION 1 0.0001
338 SECOND PRIMARY MALIGNANCY 1 0.0001
339 DEHYDRATION 16 0.0001
340 RENAL FAILURE ACUTE 5 0.0001
341 VITAMIN D DECREASED 1 0.0001
342 UNRESPONSIVE TO STIMULI 3 0.0001
343 MYOPATHY 1 0.0001
344 CARDIAC MURMUR 1 0.0001
345 PYELONEPHRITIS 1 0.0001
346 MUCOSAL INFLAMMATION 3 0.0001
347 URINE OUTPUT DECREASED 1 0.0001
348 TUMOUR LYSIS SYNDROME 1 0.0001
349 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
350 RESPIRATORY RATE INCREASED 1 0.0001
351 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
352 GALLBLADDER DISORDER 2 0.0001
353 ANAL INCONTINENCE 1 0.0001
354 LEUKOCYTOSIS 2 0.0001
355 RESTLESS LEGS SYNDROME 2 0.0001
356 DYSURIA 4 0.0001
357 UROSEPSIS 1 0.0001
358 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
359 DEMENTIA 3 0.0001
360 HEPATIC FUNCTION ABNORMAL 4 0.0001
361 APPENDICITIS 1 0.0001
362 FLANK PAIN 1 0.0001
363 ARTERIOSCLEROSIS 1 0.0001
364 SQUAMOUS CELL CARCINOMA 1 0.0001
365 BLOOD SODIUM DECREASED 2 0.0001
366 CONSTIPATION 23 0.0001
367 PROTEINURIA 2 0.0001
368 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
369 VITAMIN D DEFICIENCY 1 0.0001
370 HEPATOMEGALY 1 0.0001
371 DYSPEPSIA 10 0.0001
372 HAEMATOCRIT DECREASED 2 0.0001
373 BLADDER DISORDER 1 0.0001
374 INABILITY TO AFFORD MEDICATION 1 0.0001
375 SALIVARY HYPERSECRETION 1 0.0001
376 LEUKOPENIA 5 0.0001
377 PREMATURE BABY 3 0.0001
378 EMPHYSEMA 1 0.0001
379 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
380 TASTE DISORDER 2 0.0001
381 THROMBOCYTOPENIA 11 0.0001
382 TOOTH ABSCESS 1 0.0001
383 SUBARACHNOID HAEMORRHAGE 1 0.0001
384 NEUTROPHIL COUNT DECREASED 4 0.0001
385 RIB FRACTURE 2 0.0001
386 SKELETAL INJURY 1 0.0001
387 HYPERBILIRUBINAEMIA 1 0.0001
388 TOOTH LOSS 2 0.0001
389 VENTRICULAR EXTRASYSTOLES 1 0.0001
390 PULMONARY HYPERTENSION 2 0.0001
391 ABDOMINAL DISTENSION 10 0.0001
392 BONE DENSITY DECREASED 3 0.0001
393 NEUTROPENIA 13 0.0001
394 JOINT DISLOCATION 1 0.0001
395 FULL BLOOD COUNT ABNORMAL 1 0.0001
396 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
397 LIVER FUNCTION TEST INCREASED 2 0.0001
398 DECREASED ACTIVITY 1 0.0001
399 PHARYNGITIS STREPTOCOCCAL 1 0.0001
400 STEVENS-JOHNSON SYNDROME 2 0.0001
401 TRANSAMINASES INCREASED 2 0.0001
402 SKIN DISORDER 3 0.0001
403 TOOTH DISORDER 2 0.0001
404 URINARY RETENTION 3 0.0001
405 PANCREATITIS ACUTE 2 0.0001
406 OXYGEN SATURATION DECREASED 5 0.0001
407 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
408 URINARY TRACT INFECTION 15 0.0001
409 SKIN DISCOLOURATION 4 0.0001
410 SHOCK 2 0.0001
411 PERICARDIAL EFFUSION 2 0.0001
412 DELIRIUM 3 0.0001
413 POST PROCEDURAL HAEMORRHAGE 1 0.0001
414 HYPERKALAEMIA 3 0.0001
415 PRODUCT PRESCRIBING ERROR 2 0.0001
416 WRIST FRACTURE 1 0.0001
417 ADRENAL INSUFFICIENCY 1 0.0001
418 CYTOPENIA 1 0.0001
419 RESPIRATORY DEPRESSION 1 0.0001
420 ENCEPHALOPATHY 2 0.0001
421 HYPERCALCAEMIA 1 0.0001
422 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
423 AGEUSIA 2 0.0001
424 DRY EYE 4 0.0001
425 DYSPNOEA EXERTIONAL 3 0.0001
426 HAEMATEMESIS 2 0.0001
427 FLUID RETENTION 4 0.0001
428 HIATUS HERNIA 1 0.0001
429 RESPIRATORY TRACT INFECTION 2 0.0001
430 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
431 QUALITY OF LIFE DECREASED 1 0.0001
432 JAUNDICE 2 0.0001
433 PNEUMONIA 24 0.0001
434 NEUROPATHY PERIPHERAL 7 0.0001
435 OSTEOPOROSIS 3 0.0001
436 RESPIRATORY DISTRESS 2 0.0001
437 MENTAL STATUS CHANGES 2 0.0001
438 BLOOD TEST ABNORMAL 1 0.0001
439 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
440 PAIN IN JAW 2 0.0001
441 DIALYSIS 1 0.0001
442 SINUS TACHYCARDIA 1 0.0001
443 INTENTIONAL DOSE OMISSION 2 0.0001
444 CARDIOGENIC SHOCK 1 0.0001
445 GASTROENTERITIS 1 0.0001
446 RENAL INJURY 2 0.0001
447 BLOOD POTASSIUM DECREASED 2 0.0001
448 HEPATIC FAILURE 2 0.0001
449 APHASIA 2 0.0001
450 CORONARY ARTERY DISEASE 2 0.0001
451 CHRONIC KIDNEY DISEASE 5 0.0001
452 PLATELET COUNT DECREASED 7 0.0001
453 NEPHROLITHIASIS 3 0.0001
454 ANKLE FRACTURE 1 0.0001
455 BLOOD CHOLESTEROL INCREASED 3 0.0001
456 EJECTION FRACTION DECREASED 1 0.0001
457 PRODUCT USE COMPLAINT 1 0.0001
458 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
459 HEAD INJURY 2 0.0001
460 PULMONARY EMBOLISM 6 0.0001
461 ULCER 1 0.0001
462 HIP FRACTURE 2 0.0001
463 HYPOGLYCAEMIA 3 0.0001
464 BLOOD CREATININE INCREASED 4 0.0001
465 VIRAL INFECTION 2 0.0001
466 COAGULOPATHY 1 0.0001
467 BLOOD UREA INCREASED 1 0.0001
468 HEMIPARESIS 1 0.0001
469 HAEMATURIA 2 0.0001
470 GASTRIC DISORDER 2 0.0001
471 OFF LABEL USE 51 0.0001
472 ORTHOSTATIC HYPOTENSION 1 0.0001
473 NEUROTOXICITY 1 0.0001
474 AMENORRHOEA 1 0.0001
475 COLD SWEAT 1 0.0001
476 LYMPHOCYTE COUNT DECREASED 1 0.0001
477 BRADYCARDIA 3 0.0001
478 LYMPHADENOPATHY 2 0.0001
479 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
480 TACHYCARDIA 5 0.0001
481 ABDOMINAL PAIN 13 0.0001
482 GOUT 1 0.0001
483 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
484 TOOTHACHE 1 0.0001
485 OSTEOMYELITIS 1 0.0001
486 BONE DISORDER 1 0.0001
487 END STAGE RENAL DISEASE 1 0.0001
488 RESTLESSNESS 2 0.0001
489 OROPHARYNGEAL PAIN 5 0.0001
490 WEIGHT DECREASED 15 0.0001
491 HEPATIC STEATOSIS 1 0.0001
492 BACTERIAL INFECTION 1 0.0001
493 ERYTHEMA 11 0.0001
494 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
495 HEPATIC CIRRHOSIS 1 0.0001
496 INTESTINAL OBSTRUCTION 2 0.0001
497 FLATULENCE 3 0.0001
498 BLOOD URINE PRESENT 1 0.0001
499 CONVULSION 3 0.0001
500 SLEEP APNOEA SYNDROME 1 0.0001
501 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
502 SEIZURE 6 0.0001
503 CONTUSION 5 0.0001
504 PERIPHERAL SWELLING 8 0.0001
505 PLASMA CELL MYELOMA 2 0.0001
506 BONE PAIN 3 0.0001
507 BLOOD PRESSURE ABNORMAL 1 0.0001
508 UPPER LIMB FRACTURE 1 0.0001
509 CARDIAC FAILURE CONGESTIVE 4 0.0000
510 DIARRHOEA 32 0.0000
511 PLEURAL EFFUSION 3 0.0000
512 OEDEMA PERIPHERAL 6 0.0000
513 DYSKINESIA 2 0.0000
514 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
515 CARDIAC ARREST 4 0.0000
516 CARDIO-RESPIRATORY ARREST 2 0.0000
517 DERMATITIS 1 0.0000
518 RENAL IMPAIRMENT 4 0.0000
519 HALLUCINATION, VISUAL 1 0.0000
520 RETCHING 1 0.0000
521 LOSS OF CONSCIOUSNESS 6 0.0000
522 DEEP VEIN THROMBOSIS 3 0.0000
523 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
524 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
525 MELAENA 1 0.0000
526 BLOOD PRESSURE DECREASED 3 0.0000
527 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
528 LIVER DISORDER 2 0.0000
529 RASH MACULO-PAPULAR 1 0.0000
530 HEPATOTOXICITY 1 0.0000
531 GLOSSODYNIA 1 0.0000
532 PULMONARY OEDEMA 2 0.0000
533 CHROMATURIA 1 0.0000
534 HEART RATE IRREGULAR 1 0.0000
535 PYREXIA 15 0.0000
536 RENAL DISORDER 2 0.0000
537 ASTHENIA 16 0.0000
538 RASH ERYTHEMATOUS 2 0.0000
539 BLOOD PRESSURE FLUCTUATION 1 0.0000
540 BLOOD GLUCOSE DECREASED 2 0.0000
541 DIABETIC KETOACIDOSIS 1 0.0000
542 CEREBRAL INFARCTION 1 0.0000
543 AGITATION 3 0.0000
544 PAIN 25 0.0000
545 ABASIA 1 0.0000
546 PNEUMONIA ASPIRATION 1 0.0000
547 SYNCOPE 4 0.0000
548 FATIGUE 31 0.0000
549 HALLUCINATION 3 0.0000
550 DIABETES MELLITUS 3 0.0000
551 ACUTE KIDNEY INJURY 6 0.0000
552 THERAPY CESSATION 2 0.0000
553 DECREASED APPETITE 9 0.0000
554 BACK PAIN 9 0.0000
555 SEDATION 1 0.0000
556 PANCREATITIS 2 0.0000
557 THROAT TIGHTNESS 1 0.0000
558 PNEUMONITIS 1 0.0000
559 MOOD ALTERED 1 0.0000
560 ANAPHYLACTIC REACTION 2 0.0000
561 FALL 12 0.0000
562 WOUND 1 0.0000
563 NAUSEA 28 0.0000
564 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
565 HYPERSOMNIA 1 0.0000
566 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
567 CHILLS 4 0.0000
568 PRODUCT DOSE OMISSION ISSUE 10 0.0000
569 PSYCHOTIC DISORDER 1 0.0000
570 RESPIRATORY DISORDER 1 0.0000
571 JOINT SWELLING 4 0.0000
572 LACRIMATION INCREASED 1 0.0000
573 EMOTIONAL DISTRESS 4 0.0000
574 STOMATITIS 2 0.0000
575 EXPOSURE DURING PREGNANCY 2 0.0000
576 SWOLLEN TONGUE 1 0.0000
577 MALAISE 14 0.0000
578 DYSPHAGIA 3 0.0000
579 CYSTITIS 1 0.0000
580 HYPOTHYROIDISM 1 0.0000
581 RHINORRHOEA 2 0.0000
582 CONFUSIONAL STATE 5 0.0000
583 URTICARIA 5 0.0000
584 NEOPLASM PROGRESSION 1 0.0000
585 HEADACHE 18 0.0000
586 HYPERTENSION 6 0.0000
587 ANXIETY 8 0.0000
588 CEREBRAL HAEMORRHAGE 1 0.0000
589 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
590 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
591 VOMITING 13 0.0000
592 INFECTION 4 0.0000
593 BLOOD PRESSURE INCREASED 4 0.0000
594 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
595 ABNORMAL BEHAVIOUR 1 0.0000
596 ABORTION SPONTANEOUS 1 0.0000
597 CARDIAC FAILURE 2 0.0000
598 PROSTATE CANCER 2 0.0000
599 LUNG NEOPLASM MALIGNANT 1 0.0000
600 TREMOR 4 0.0000
601 RHABDOMYOLYSIS 1 0.0000
602 POLLAKIURIA 1 0.0000
603 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
604 OSTEOARTHRITIS 1 0.0000
605 BALANCE DISORDER 2 0.0000
606 DYSPNOEA 13 0.0000
607 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
608 ANGIOEDEMA 1 0.0000
609 GASTROINTESTINAL DISORDER 2 0.0000
610 MEMORY IMPAIRMENT 3 0.0000
611 ADVERSE EVENT 2 0.0000
612 ARTHRALGIA 9 0.0000
613 COGNITIVE DISORDER 1 0.0000
614 CARDIAC DISORDER 2 0.0000
615 PRODUCT USE ISSUE 4 0.0000
616 ARRHYTHMIA 1 0.0000
617 DEATH 18 0.0000
618 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
619 DRUG INTOLERANCE 2 0.0000
620 INTERSTITIAL LUNG DISEASE 1 0.0000
621 ATRIAL FIBRILLATION 2 0.0000
622 AGGRESSION 1 0.0000
623 CELLULITIS 1 0.0000
624 HAEMOGLOBIN DECREASED 2 0.0000
625 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
626 SPEECH DISORDER 1 0.0000
627 DEPRESSED MOOD 1 0.0000
628 DISTURBANCE IN ATTENTION 1 0.0000
629 TREATMENT NONCOMPLIANCE 1 0.0000
630 DIZZINESS 9 0.0000
631 PANCYTOPENIA 1 0.0000
632 ABDOMINAL DISCOMFORT 3 0.0000
633 COUGH 5 0.0000
634 BLISTER 1 0.0000
635 EYE PAIN 1 0.0000
636 MUSCULAR WEAKNESS 2 0.0000
637 EYE IRRITATION 1 0.0000
638 PALPITATIONS 2 0.0000
639 SURGERY 1 0.0000
640 DRUG INEFFECTIVE 22 0.0000
641 THERAPEUTIC RESPONSE DECREASED 1 0.0000
642 VERTIGO 1 0.0000
643 DISCOMFORT 1 0.0000
644 FEELING HOT 1 0.0000
645 CHEST PAIN 3 0.0000
646 DRY SKIN 2 0.0000
647 NEOPLASM MALIGNANT 1 0.0000
648 SOMNOLENCE 3 0.0000
649 ABDOMINAL PAIN UPPER 3 0.0000
650 VISION BLURRED 2 0.0000
651 DEVICE MALFUNCTION 1 0.0000
652 SLEEP DISORDER 1 0.0000
653 THERAPY INTERRUPTED 1 0.0000
654 BRONCHITIS 1 0.0000
655 EPISTAXIS 1 0.0000
656 DEPRESSION 3 0.0000
657 HOSPITALISATION 2 0.0000
658 DRUG DOSE OMISSION BY DEVICE 1 0.0000
659 ARTHRITIS 1 0.0000
660 DRUG INTERACTION 2 0.0000
661 TOXICITY TO VARIOUS AGENTS 2 0.0000
662 SKIN EXFOLIATION 1 0.0000
663 INTENTIONAL PRODUCT MISUSE 1 0.0000
664 INSOMNIA 3 0.0000
665 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
666 SUICIDAL IDEATION 1 0.0000
667 HYPERSENSITIVITY 2 0.0000
668 HEART RATE INCREASED 1 0.0000
669 CHEST DISCOMFORT 1 0.0000
670 SINUSITIS 1 0.0000
671 ILLNESS 1 0.0000
672 OVERDOSE 2 0.0000
673 INFLUENZA 1 0.0000
674 ASTHMA 1 0.0000
675 INCORRECT DOSE ADMINISTERED 2 0.0000
676 INJECTION SITE ERYTHEMA 1 0.0000
677 RASH 3 0.0000
678 PARAESTHESIA 1 0.0000
679 CEREBROVASCULAR ACCIDENT 1 0.0000
680 MYALGIA 1 0.0000
681 NO ADVERSE EVENT 1 0.0000
682 MUSCLE SPASMS 1 0.0000
683 BLOOD GLUCOSE INCREASED 1 0.0000
684 GAIT DISTURBANCE 1 0.0000
685 PRURITUS 2 0.0000
686 ALOPECIA 1 0.0000
687 WEIGHT INCREASED 1 0.0000
688 FEELING ABNORMAL 1 0.0000
689 PAIN IN EXTREMITY 1 0.0000
690 INJECTION SITE PAIN 1 0.0000